Axon Enterprise (NASDAQ:AXON) President Joshua Isner Sells 2,041 Shares

Axon Enterprise, Inc (NASDAQ:AXON) President Joshua Isner sold 2,041 shares of the firm’s stock in a transaction dated Wednesday, December 3rd. The shares were sold at an average price of $535.11, for a total value of $1,092,159.51. Following the completion of the transaction, the president directly owned 269,502 shares in the company, valued at $144,213,215.22. This trade represents a 0.75% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Axon Enterprise Trading Up 1.1%

AXON opened at $543.55 on Thursday. Axon Enterprise, Inc has a 52-week low of $469.24 and a 52-week high of $885.91. The firm has a market capitalization of $42.89 billion, a P/E ratio of 172.01, a P/E/G ratio of 122.46 and a beta of 1.40. The company has a quick ratio of 2.89, a current ratio of 3.12 and a debt-to-equity ratio of 0.57. The firm’s 50 day moving average is $645.68 and its 200-day moving average is $722.81.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Wednesday, November 5th. The biotechnology company reported $1.17 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.46). Axon Enterprise had a return on equity of 4.29% and a net margin of 10.05%.The business had revenue of $710.64 million during the quarter, compared to analyst estimates of $704.83 million. During the same quarter last year, the firm posted $1.45 EPS. The company’s revenue was up 30.6% compared to the same quarter last year. Analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Analysts Set New Price Targets

Several brokerages have recently commented on AXON. Needham & Company LLC reiterated a “buy” rating and issued a $870.00 target price on shares of Axon Enterprise in a research report on Wednesday, September 24th. Wall Street Zen downgraded shares of Axon Enterprise from a “hold” rating to a “sell” rating in a research report on Saturday, November 8th. The Goldman Sachs Group dropped their price target on Axon Enterprise from $940.00 to $800.00 and set a “buy” rating on the stock in a research report on Wednesday, November 5th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Axon Enterprise in a research note on Monday. Finally, Barclays dropped their price objective on shares of Axon Enterprise from $861.00 to $702.00 and set an “overweight” rating on the stock in a report on Thursday, November 6th. Fifteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $814.00.

Hedge Funds Weigh In On Axon Enterprise

Several large investors have recently bought and sold shares of AXON. Brighton Jones LLC acquired a new stake in Axon Enterprise in the 4th quarter valued at about $480,000. iA Global Asset Management Inc. grew its stake in shares of Axon Enterprise by 2.6% in the 1st quarter. iA Global Asset Management Inc. now owns 8,434 shares of the biotechnology company’s stock worth $4,436,000 after purchasing an additional 215 shares during the last quarter. Vision Financial Markets LLC bought a new stake in shares of Axon Enterprise in the 1st quarter worth approximately $53,000. Ithaka Group LLC bought a new stake in shares of Axon Enterprise in the 1st quarter worth approximately $3,923,000. Finally, Wealthspire Advisors LLC lifted its stake in Axon Enterprise by 13.5% during the first quarter. Wealthspire Advisors LLC now owns 420 shares of the biotechnology company’s stock valued at $221,000 after purchasing an additional 50 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.